⌘K

Login Start Free

Home/Filings/4/0000882796-25-000021

4//SEC Filing

Frank Steven 4

Accession 0000882796-25-000021

CIK 0000882796other

View on SEC.gov Company Profile

Filed

Dec 1, 7:00 PM ET

Accepted

Dec 2, 4:10 PM ET

Size

4.5 KB

Accession

0000882796-25-000021

Insider Transaction Report

Form 4

Period: 2025-11-28

BIOCRYST PHARMACEUTICALS INCBCRX

Director

Transactions

Award
Common Stock
2025-11-28$7.18/sh+1,566$11,244→ 17,618 total

Footnotes (1)

[F1]Shares of Common Stock issued to the reporting person in lieu of 100% of the quarterly cash Board Member retainer of $11,250.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

BIOCRYST PHARMACEUTICALS INC

CIK 0000882796

Entity typeother

Related Parties

1

filerCIK 0001583886

Filing Metadata

Form type: 4
Filed: Dec 1, 7:00 PM ET
Accepted: Dec 2, 4:10 PM ET
Size: 4.5 KB

View on SEC.gov